Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pain 3Neoplasms 3Gastrointestinal Neoplasms 2Depression 2Anxiety Disorders 2Peripheral Nervous System Diseases 1Pain, Postoperative 1Otolaryngeal Cancer 1Neurotoxicity Syndromes 1Mucositis 1Lung Neoplasms 1Head and Neck Neoplasms 1Cancer Pain 1Breast Neoplasms 1Agnosia 1Acute Pain 1

Interventions

Oxaliplatin 4Leucovorin 4Irinotecan 4Fluorouracil 4Capecitabine 3Bevacizumab 3cobimetinib 2Tomography, X-Ray Computed 2Surveys and Questionnaires 2Standard of Care 2Specimen Handling 2Panitumumab 2Magnetic Resonance Spectroscopy 2Ketamine 2Hydroxychloroquine 2Cyclophosphamide 2Cisplatin 2ulixertinib 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1tivozanib 1sodium thiosulfate 1rucaparib 1romiplostim 1rilotumumab 1regorafenib 1pralsetinib 1ponatinib 1pembrolizumab 1osimertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Gastrointestinal Neoplasms × Ketamine × Clear all
NCT06077487 2025-05-21

Ketamine-assisted Therapy for Advanced GI Cancer

University of California, San Francisco

Phase 4 Terminated
1 enrolled 10 charts
Gastrointestinal

Gastrointestinal Neoplasms, Acute Pain

NCT06001372 2025-04-16

TREK

University of Utah

Phase EARLY_PHASE1 Terminated
2 enrolled 9 charts
Gastrointestinal

Anxiety Disorders, Depression, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡